Mymox 250 / 500 250 mg or 500 mg Capsules, hard.
PDF Leaflet Revision Date: 28 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Infections caused by susceptible non-penicillinase-producing organisms.
Dosage (summary)
Adults: 750 mg u2013 1.5 g/day; serious infections up to 6 g/day.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; excreted in breast milk with possible risk of sensitization.
Key Drug Interactions
- Oral anticoagulants
- Probenecid
- Allopurinol
- Tetracyclines
- Methotrexate
Contraindications
- Hypersensitivity to penicillins
- History of hypersensitivity to beta-lactam antibiotics
Common side effects
- Diarrhoea
- Nausea
- Skin rash
Counselling Points
- Take with water without opening capsule
- Monitor for allergic reactions
- May reduce efficacy of oral contraceptives
Serious warnings
- Serious hypersensitivity reactions
- Convulsions in renal impairment
- Antibiotic-associated colitis
Important Disclaimer
The Mymox 250 / 500 250 mg or 500 mg Capsules, hard. professional information leaflet below is the property of Unichem Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
